[ORGANIZATION]
ABDA
Featured in 4 tracked stories · first seen
Situations
Novo Nordisk pivots strategy to counter patent cliff
112 clusters · 548 sources · last updated
Latest: Novo Nordisk faces intense competition in obesity drug market
Novo Nordisk is implementing a strategic reset to address long-term growth concerns and the looming patent expiration of semaglutide in the early 2030s. To diversify its portfolio and counter competition from Eli Lilly,
German healthcare competency and reform disputes
2 clusters · 2 sources · last updated
Latest: German healthcare reforms face opposition from medical associations
Germany is experiencing ongoing tension between medical associations and pharmacy representatives regarding the division of healthcare responsibilities and systemic reforms. Initial debates focused on the scope of medic
Also covered in
-
German pharmacies face competition and procurement shifts
[BUSINESS] · 2 sources ·